Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Sewage reclamation process as multifactorial public health risk concern: a longitudinal study

  • Cuevas Ferrando, Enric
  • Girón-Guzmán, Inés
  • Sánchez-Alberola, Santiago
  • Falcó, Irene
  • Díaz-Reolid, Azahara
  • Puchades Colera, Pablo
  • Ballesteros, Sandra
  • Coll, José María
  • Núñez, Eugenia
  • Fabra, María José
  • López-Rubio, Amparo
  • Sánchez Moragas, Gloria
This year-long research analysed emerging risks in influent, effluent wastewaters and biosolids from six wastewater treatment plants in Spain's Valencian Region. Specifically, it focused on human enteric and respiratory viruses, bacterial and viral faecal contamination indicators, extended spectrum beta-lactamases-producing Escherichia coli and antibiotic resistance genes. Additionally, particles and microplastics in biosolid and wastewater samples were assessed. Human enteric viruses were prevalent in influent wastewater, with limited post-treatment reduction. Wastewater treatment effectively eliminated respiratory viruses, except for low levels of SARS-CoV-2 in effluent and biosolid samples, suggesting minimal public health risk. Antibiotic resistance genes and microplastics were persistently found in effluent and biosolids, thus indicating treatment inefficiencies and potential environmental dissemination. This multifaced research sheds light on diverse contaminants present after water reclamation, emphasizing the interconnectedness of human, animal, and environmental health in wastewater management. It underscores the need for a One Health approach to address the United Nations Sustainable Development Goals., This research was supported by project the Lagoon project (PROMETEO/2021/044) and MCEC WATER (PID 2020 116789 RB C 42 AEI/FEDER, UE). IATA-CSIC is a Centre of Excellence Severo Ochoa (CEX2021- 001189-S MCIN/AEI / 10.13039/ 501100011033). IF (MS21-006) and SB are supported by a postdoctoral contract grant for the requalification of the Spanish university system from the Ministry of Universities of the Government of Spain, financed by the European Union (NextGeneration EU).IG-G is recipient of a predoctoral contract from the Generalitat Valenciana (ACIF/2021/181), EC-F is recipient of a postdoctoral contract from the MICINN Call 2018 (PRE2018-083753) and AP-C is recipient of the contract Juan de la Cierva – Incorporación (IJC2020-045382-I) which is financed by MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU/PRTR". The authors thank Andrea López de Mota, Arianna Pérez, Agustín Garrido Fernández, Mercedes Reyes Sanz, José Miguel Pedra Tellols, and Alcira Reyes Rovatti for their technical support, No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Endo-β-N-acetylglucosaminidase EndoE from infant gut Enterococcus faecalis neutralizes SARS-CoV-2 by interacting with the viral spike protein

  • Moya Gonzálvez, Eva M.
  • López-Navarro, Sergi
  • Avilés-Alía, Ana I.
  • Geller, Ron
  • Yebra, María Jesús
  • Rodríguez-Díaz, Jesús
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is extensively N-glycosylated, and unlike the receptor-binding domain of the S1 subunit which undergoes frequent mutations, the glycosylation sites remain conserved across most variants of concern. In this study, we cloned and purified EndoE, an endo-β-N-acetylglucosaminidase enzyme from an Enterococcus faecalis strain isolated in our laboratory (E8 strain). The purified EndoE effectively removed glycans from the S1 protein of SARS-CoV-2 spike. We constructed a catalytically inactive mutant form of EndoE, termed EndoE (Mut). Both wild-type EndoE and the EndoE (Mut) demonstrated neutralizing activity against SARS-CoV-2 S pseudotyped virus infection, with IC50 values of 81.26 ± 8.42 nM and 63.15 ± 5.06 nM, respectively. Enzyme-linked immunosorbent assay revealed that both forms of EndoE bound to the S1 protein. Moreover, commercial EndoH enzyme, which also cleaves N-glycosylation, did not exhibit neutralizing activity against SARS-CoV-2 S pseudotyped virus at any tested concentration. In contrast, the plant lectin Concanavalin A demonstrated the most potent neutralization ability, with an IC50 of 40.89 ± 24.04 nM. Importantly, neither form of EndoE displayed toxicity even at the highest tested concentration (6,250 nM), whereas Concanavalin A exhibited toxicity to cells at a concentration as low as 157 nM. These findings shed light on the role of glycosidases in SARS-CoV-2 infection and offer a novel avenue for the development of antiviral strategies., This work is part of the Grant PID2020-115403RB (C21 and C22) funded by the Spanish Ministry of Science and Innovation (MICIN)/Spanish State Research Agency (AEI)/10.13039/501100011033. The study was also supported by Valencian Government grant AICO/2021/033. RG acknowledged funding from grants SGL2021-03-009 and SGL2021-03-052 from European Union NextGenerationEU/PRTR through the CSIC Global Health Platform established by EU Council Regulation 2020/2094. EMM-G was supported by the Grant PRE2018-085768 funded by MICIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. SL-N was supported by the FPU22/00443 grant from the Spanish Ministry of Science and Innovation (MICIN). IATA-CSIC is a Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/501100011033)., No